Drug target · HCRTR2
OX2R
Orexin receptor type 2 (hypocretin receptor 2)
3 compounds in the CNS pipeline act on OX2R.
Compounds targeting OX2R
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| OveporextonprimarySmall molecule | Agonist | — | Filed (NDA)Narcolepsy | Takeda Pharmaceutical Company Limited |
| AlixorextonprimarySmall molecule | Agonist | — | Phase 3Narcolepsy | Alkermes plc |
| Seltorexant (JNJ-42847922)primarySmall molecule | Antagonist | pKi 8 | Phase 3Major depressive disorder | Johnson & Johnson |